Skip to main content
Acumen Pharmaceuticals, Inc. (ABOS)
NASDAQ: ABOS · Real-Time Price · USD
3.140
-0.170 (-5.14%)
At close: Mar 9, 2026, 4:00 PM EDT
3.210
+0.070 (2.23%)
After-hours: Mar 9, 2026, 4:10 PM EDT

Acumen Pharmaceuticals Revenue

Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
61
Market Cap
192.02M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2024---
Dec 31, 2023---
Dec 31, 2022---
Dec 31, 2021---
Dec 31, 20201.44M-261.00K-15.38%
Dec 31, 2019 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Arcturus Therapeutics Holdings 82.03M
Compugen 72.76M
Protalix BioTherapeutics 61.84M
Editas Medicine 46.38M
Cibus 3.79M
Humacyte 1.57M
NeOnc Technologies Holdings 59.99K
Revenue Rankings

ABOS News

More News